[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334514-105":59,"doc-detail-334514-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","guanylate-binding-protein-4-shapes-an-inflamed-tumor-microenvironment-and-identifies-immuno-hot-tumors","Guanylate binding protein 4 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors","","Guanylate binding protein 4 (GBP4), an interferon- and cytokine-induced factor, is evaluated for its relationship with antitumor immunity and tumor microenvironment (TME) immunological features. A pan-cancer analysis characterizes GBP4 expression and immunological functions, then tests correlations with immunological features in non-small cell lung cancer (NSCLC). The study also links GBP4 to immunobiomarkers, including m6A-related genes, and assesses its value for predicting clinical traits and treatment responses in NSCLC, supported by immunomodulators, immune cells, and checkpoints.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/guanylate-binding-protein-4-shapes-an-inflamed-tumor-microenvironment-and-identifies-immuno-hot-tumors/334514/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/guanylate-binding-protein-4-shapes-an-inflamed-tumor-microenvironment-and-identifies-immuno-hot-tumors/334514.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of studying GBP4 in cancer immunity?","Question",{"text":112,"@type":113},"To clarify how GBP4 relates to antitumor immunity and immunological characteristics of the tumor microenvironment, which had remained uncertain.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were GBP4 expression and immunological functions analyzed?",{"text":117,"@type":113},"A pan-cancer analysis examined GBP4 expression patterns and immunological functions, followed by correlation studies in NSCLC patients for TME immunological features.",{"name":119,"@type":110,"acceptedAnswer":120},"What does GBP4 indicate regarding tumor types and treatment responsiveness?",{"text":121,"@type":113},"GBP4 expression is associated with an inflamed TME and immuno-hot tumors and serves as a predictor of enhanced responsiveness to anti-EGFR therapy and immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334514,1790711372,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Journal of Cancer Research and Clinical Oncology (2024) 150:90  \n[https://doi.org/10.1007/s00432-024-05605-9](https://doi.org/10.1007/s00432-024-05605-9)  \nGuanylate binding protein 4 shapes an inflamed tumor microenvironment and identifies immuno‑hot tumors  \nWeijian Zhou1 · GaoshaerYeerkenbieke1 · Yumei Zhang1,2 · Mingwang Zhou1 · Jin Li1  \nReceived: 20 September 2023 / Accepted: 1 January 2024 / Published online: 12 February 2024 © The Author(s) 2024  \nAbstract  \nPurpose Guanylate binding protein 4 (GBP4) is induced by interferons and various cytokines and has been recognized as functionally relevant in numerous types of human cancers. While the role of GBP4 in cancer has been preliminarily summarized, its correlation with antitumor immunity remains unclear and requires further research.  \nMethods First, a comprehensive pan-cancer analysis was conducted, focusing on GBP4’s expression patterns and immunological functions. Subsequently, we explored the correlations between GBP4 and immunological features within the tumor microenvironment (TME) in non-small cell lung cancer (NSCLC) patients. Additionally, we examined the relationships between GBP4 and emerging immunobiomarkers, such as N6-methyladenosine (m6A) genes. Moreover, we assessed the utility of GBP4 in predicting the clinical characteristics and treatment responses of patients with NSCLC.  \nResults Pan-cancer analysis revealed that GBP4 plays a positive role in most cancer types via the majority of immunomodulators. Furthermore, GBP4 demonstrated positive associations with immunomodulatory factors, tumor-infiltrating immune cells (TIICs) and inhibitory immune checkpoints. Remarkably, the expression of GBP4 was found to be a predictor of significantly enhanced responsiveness to anti-EGFR therapy and immunotherapy.  \nConclusions GBP4 expression profiles offer a promising avenue for identifying highly immunogenic tumors across a wide spectrum of cancers. GBP4 holds potential as a robust pan-cancer biomarker for assessing the immunological characteristics of tumors, with particular relevance to its ability to predict therapeutic responses, notably in the context of anti-EGFR therapy and immunotherapy.  \nKeywords GBP4 · Tumor immunotherapy · Pancancer analysis · Bioinformatics analysis  \nIntroduction  \nGuanylate binding proteins (GBPs) were first identified in the late 1970s; further studies revealed their mechanism of induction via interferons (IFNs) and other cytokines, and they have been used as markers of IFN responsiveness in both cells and organisms (Vestal 2005) . GTPases are highly evolutionarily conserved proteins that offer protection against multiple invading pathogens (Kim et al. 2012) . Previous studies have shown that the GBP family is highly important for antibacterial defense and that Guanylate  \n* Jin Li[lijin@csco.org.cn](lijin@csco.org.cn)  \n1 Department of Oncology, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai 200123, China  \n2 Department of VIP Clinic, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai 200123, China  \nbinding protein 4 (GBP4) is a key inflammasome adaptor required for prostaglandin biosynthesis and bacterial clearance by neutrophils (Wandel et al. 2020 ; Tyrkalska et al. 2016). GBP4 was also found to be highly expressed in multiple cancer types, including melanoma (Gambichler et al. 2022) and colorectal cancer (Xu et al. 2020) . In another study, GBP4 expression was shown to be correlated with poor overall survival (OS) in patients with ovarian cancer (Huo et al. 2021). However, the relationship between GBP4 and tumor immunity has not been explored.  \nCancers develop within complex tissue environments that consist of diverse types of immune cells. The high heterogeneity within the tumor microenvironment (TME) remains a key obstacle in understanding and treating cancer (Duanet al. 2020) . Based on the characteristics ofthe TME, tumors can be classified into two different types: hot and col","cbCainXJFfaRBvbc","https://ap.wps.com/l/cbCainXJFfaRBvbc","pdf",8259130,13,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Tumor microenvironment and hot vs cold tumors\n# Materials and methods\n## Data source and preprocessing\n## Prediction of immunological characteristics of the TME","[{\"question\":\"What is the main purpose of studying GBP4 in cancer immunity?\",\"answer\":\"To clarify how GBP4 relates to antitumor immunity and immunological characteristics of the tumor microenvironment, which had remained uncertain.\"},{\"question\":\"How were GBP4 expression and immunological functions analyzed?\",\"answer\":\"A pan-cancer analysis examined GBP4 expression patterns and immunological functions, followed by correlation studies in NSCLC patients for TME immunological features.\"},{\"question\":\"What does GBP4 indicate regarding tumor types and treatment responsiveness?\",\"answer\":\"GBP4 expression is associated with an inflamed TME and immuno-hot tumors and serves as a predictor of enhanced responsiveness to anti-EGFR therapy and immunotherapy.\"}]","Guanylate binding protein 4 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors | PDF",1790007013,33]